Neuropace, Inc.

Q2 2022 13F Holders

Symbol
NPCE
CUSIP
641288105
Type
Equity
Class
COM
Num filings
33
Total reported value, excl. options
$91.2 M
Manager Report Date Value ($000) Shares Option Type